GRO Biosciences

Boston, United States

GRO Biosciences is a biotechnology company that develops a protein therapeutics technology to improve treatments across multiple diseases.

$60.3M raised

Jul 2024

Series B

Biotechnology Health Diagnostics Medical Pharmaceutical Therapeutics

Top Investors

Alumni Ventures National Science Foundation Redmile Group Digitalis Ventures Pillar VC

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about GRO Biosciences

How much funding has GRO Biosciences raised?

GRO Biosciences has raised $60.3M in total funding. The most recent round was Series B. The last funding was announced in July 2024.

Who are GRO Biosciences's investors?

GRO Biosciences's investors include Alumni Ventures, National Science Foundation, Redmile Group, Digitalis Ventures, Pillar VC.

Where is GRO Biosciences headquartered?

GRO Biosciences is headquartered in Boston, United States.

What does GRO Biosciences do?

GRO Biosciences is a biotechnology company that develops a protein therapeutics technology to improve treatments across multiple diseases.

What stage is GRO Biosciences at?

GRO Biosciences is at the Series B stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated July 19, 2024.

MLA

"GRO Biosciences — Funding & Investors." VCBacked, July 19, 2024, https://www.vcbacked.co/company/gro-biosciences. Accessed July 3, 2026.

APA

VCBacked. (2024). GRO Biosciences — Funding & Investors. Retrieved July 3, 2026, from https://www.vcbacked.co/company/gro-biosciences

Wikipedia (cite web)

{{cite web |title=GRO Biosciences — Funding & Investors |url=https://www.vcbacked.co/company/gro-biosciences |website=VCBacked |access-date=July 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated July 19, 2024.

Similar Companies in Biotechnology

View all

Allterum Therapeutics

Houston$1.0M

AlpalifeBio

Woburn$9.8M

Renaissance BioScience

Advanced Microbiome Interventions

Amsterdam$300K